Pages that link to "Q39414277"

The following pages link to Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients. (Q39414277):

Displaying 16 items.

• Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection (Q31149395) (← links)
• Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV. (Q39173801) (← links)
• Adipose Tissue in HIV Infection (Q40038736) (← links)
• Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults (Q40116616) (← links)
• HIV-1 viral protein R (Vpr) induces fatty liver in mice via LXRα and PPARα dysregulation: implications for HIV-specific pathogenesis of NAFLD. (Q42657454) (← links)
• Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection (Q47547885) (← links)
• NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk? (Q54232638) (← links)
• Benefit of early versus deferred antiretroviral therapy on progression of liver fibrosis among people with HIV in the START randomized trial (Q57294432) (← links)
• Solid Organ Transplantation for HIV-Infected Individuals (Q59357554) (← links)
• A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing? (Q64240956) (← links)
• New drugs for non-alcoholic steatohepatitis and HIV infection: great expectations with a great absent? (Q89692272) (← links)
• Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy (Q92123914) (← links)
• Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection (Q92130395) (← links)
• Hepatic steatosis among people living with HIV in Southern Brazil: prevalence and risk factors (Q95301391) (← links)
• Protocol for a phase IV, open-label feasibility study investigating non-invasive markers of hepatic fibrosis in people living with HIV-1 and non-alcoholic fatty liver disease randomised to receiving optimised background therapy (OBT) plus maraviroc (Q97417638) (← links)
• Repurposing Metformin in Nondiabetic People With HIV: Influence on Weight and Gut Microbiota (Q99609907) (← links)